cognitive cybersecurity intelligence

News and Analysis

Search

CRISPR-Cas9 Targets Lung Cancer Using Cryo-Shocked Tumor Cells

Scientists from Zhejiang University have created a new delivery method for CRISPR-Cas9 which is more effective at treating lung cancer than lipid nanoparticles. By treating tumour cells with rapid liquid nitrogen, they can be used as carriers for gene editing tools, while maintaining their structure and surface receptor function. The team found that this technique, termed “cryo-shock,” was effective in targeting the lung and extending survival time in a mouse model of non-small cell lung cancer (NSCLC).

Source: www.genengnews.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts